Heart Failure Remote Monitoring
Transforming Heart Failure Management Through Intelligent Remote Monitoring.
The context
The US Heart Failure Market: A Public Health Urgency
Heart Failure (HF) remains one of the most significant public health challenges of the 21st century. At Implicity, we are pushing the boundaries of technology to provide cardiologists with proactive insights, enabling clinical intervention before a patient’s condition deteriorates.
In the United States, heart failure has reached critical levels, placing unprecedented pressure on the healthcare system.
Source: HFSA Heart Failure Epidemiology and Outcomes Statistics (2025) & AHA 2026 Statistical Update.
Our solution
The Implicity Solution: Intelligence for Your Implanted Patients
For heart failure patients with Cardiac Implantable Electronic Devices (CIEDs)—such as pacemakers, ICDs, and CRT—Implicity offers a unique, universal remote monitoring platform.
The Implicity Solution: Intelligence for Your Implanted Patients
For heart failure patients with Cardiac Implantable Electronic Devices (CIEDs)—such as pacemakers, ICDs, and CRT—Implicity offers a unique, universal remote monitoring platform.
1. Centralization of Physiological Data
Our platform automatically aggregates data from devices across all major manufacturers (Abbott, Biotronik, Boston Scientific, Medtronic and Microport). It allows for real-time tracking of critical indicators, including:
→ Arrhythmia burden (Atrial Fibrillation)
→ Patient physical activity
→ Nighttime heart rate
→ Thoracic impedance, a key indicator of pulmonary fluid accumulation
The platform also displays proprietary alerts related to the heart failure hospitalization index.
2. SignalHF¹: The FDA-Cleared Predictive Algorithm
The true innovation of Implicity lies in SignalHF, our cutting-edge AI-based algorithm.
→ Anticipating Crises: SignalHF continuously analyzes physiological data trends to identify early warning signs of cardiac decompensation.
→ Agnostic and Powerful: As the first algorithm of its kind to be FDA cleared, it is compatible with devices from multiple manufacturers, providing a standardized solution for your entire patient population.
→ Reducing Hospitalizations: By alerting clinical teams weeks before a critical event occurs, SignalHF enables early therapeutic adjustments, helping patients avoid the Emergency Room.
Why Choose Implicity for Your HF Patients?
Ready to Transform Your Clinical Follow-up?
Discover how Implicity can help you reduce heart failure hospitalizations while improving your patients’ quality of life.
¹SignalHF FDA cleared Class II medical device. Manufacturer: Implicity. The SignalHF System is intended for use by qualified healthcare professionals (HCP) managing patients over 18 years old who are receiving physiological monitoring for Heart Failure surveillance and implanted with a compatible Cardiac Implantable Electronic Devices (CIED) (i.e., compatible pacemakers, ICDs, and CRTs). The SignalHF System provides additive information to use in conjunction with standard clinical evaluation.
The SignalHF HF Score is intended to calculate the risk of HF for a patient in the next 30 days. This System is intended for adjunctive use with other physiological vital signs and patient symptoms and information and is not intended to independently direct therapy. See the instructions for use for more information. SignalHF is not available for sale in Europe.
²Niraj Varma, Eloi Marijon, Éric Vicaut, Serge Boveda, Alexandre Abraham, Issam Ibnouhsein, Arnaud Rosier, Pascal Defaye, Jagmeet P. Singh, Impact of a Universal Monitoring system (“Third party”) on Outcomes among ICD patients: A Nationwide Study, Heart Rhythm, 2024.
